Preeclampsia and coagulation

doi:10.3877/cma.j.issn.2095-3259.2021.03.005

Abstract

Abstract:

The hypercoagulable state of pregnancy is amplified further in preeclampsia(PE). Prenatal monitoring of coagulation indicators has an important clinical significance and may assist the clinician in the prevention and management of PE. With the increased knowledge in the coagulation mechanism of PE, it has received more attention that anticoagulants such as aspirin and low molecular weight heparin can improve the prognosis of the mother and fetus in PE.

Key words: Preeclampsia, Blood coagulation, Anticoagulants

Mengying Wu, Yin Zhao. Preeclampsia and coagulation[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2021, 10(03): 147-150.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2021.03.005

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2021/V10/I03/147

References 25

[9]	Torricelli M, Sabatini L, Florio P, et al. Levels of antibodies against protein C and protein S in pregnancy and in preeclampsia [J]. J Matern Fetal Neonatal Med, 2009，22(11): 993-999.
[10]	Ebina Y, Ieko M, Naito S, et al. Low levels of plasma protein S, protein C and coagulation factor XII during early pregnancy and adverse pregnancy outcome [J]. Thromb Haemost, 2015，114(1): 65-69.
[11]	Oliver JJ, Webb DJ, Newby DE. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans [J]. Arterioscler Thromb Vasc Biol, 2005，25(12): 2470-2479.
[12]	Mone F, Mulcahy C, Mcparland P, et al. Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial [J]. BMJ Open, 2018，8: 1-9.
[13]	中华医学会妇产科学分会妊娠期高血压疾病学组．妊娠期高血压疾病诊治指南(2020) [J]. 中华妇产科杂志，2020，55(4): 227-238.
[14]	Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222 [J]. Obstet Gynecol, 2020，135(6): e237-e260.
[15]	Brown MA, Magee LA, Kenny LC, et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice[J]. Hypertension, 2018，72(1): 24-43.
[16]	De Luca G, Secco GG, Iorio S, et al. Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study [J]. Blood Coagul Fibrinolysis, 2012，23(8): 756-759.
[17]	Banala C, Moreno S, Cruz Y, et al. Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension [J]. Am J Obstet Gynecol, 2020，223 (3): 419.e1-e16.
[18]	Mclaughlin K, Baczyk D, Potts A, et al. Low Molecular Weight Heparin Improves Endothelial Function in Pregnant Women at High Risk of Preeclampsia [J]. Hypertension, 2017，69(1): 180-188.
[19]	Rodger MA, Gris JC, De Vries JIP, et al. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials [J]. Lancet, 2016，388(10060): 2629-2641.
[20]	D′souza R, Keating S, Walker M, et al. Unfractionated heparin and placental pathology in high-risk pregnancies: secondary analysis of a pilot randomized controlled trial [J]. Placenta, 2014，35(10): 816-823.
[21]	中华医学会妇产科学分会产科学组. 妊娠期及产褥期静脉血栓栓塞症预防和诊治专家共识 [J]. 中华妇产科杂志，2021，56(4): 236-243.
[22]	Backe SK, Lyons GR. High-dose tinzaparin in pregnancy and the need for urgent delivery [J]. Br J Anaesth, 2002，89(2): 331-334.
[23]	Roberge S, Demers S, Nicolaides KH, et al. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis [J]. Ultrasound Obstet Gynecol, 2016，47(5): 548-553.
[24]	Haddad B, Winer N, Chitrit Y, et al. Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial [J]. Obstet Gynecol, 2016，128 (5): 1053-1063.
[25]	Zhang Y, Shen F, Yang W, et al. Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study [J]. Int J Gynaecol Obstet, 2021，154(2): 337-342.
[1]	Boij R, Svensson J, Nilsson-Ekdahl K, et al. Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia [J]. Am J Reprod Immunol, 2012，68(3): 258-270.
[2]	Güngör ZB, Ekmekçi H, Tüten A, et al. Is there any relationship between adipocytokines and angiogenesis factors to address endothelial dysfunction and platelet aggregation in untreated patients with preeclampsia? [J]. Arch Gynecol Obstet, 2017，296(3): 495-502.
[3]	Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management [J]. Am J Obstet Gynecol, 2015，213(4): 452-463.
[4]	Peraçoli MT, Menegon FT, Borges VT, et al. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia [J]. J Reprod Immunol, 2008，79(1): 79-84.
[5]	Duan Z, Li C, Leung WT, et al. Alterations of Several Serum Parameters Are Associated with Preeclampsia and May Be Potential Markers for the Assessment of PE Severity [J]. Dis Markers, 2020，2020: 1-7.
[6]	Han L, Liu X, Li H, et al. Blood Coagulation Parameters and Platelet Indices: Changes in Normal and Preeclamptic Pregnancies and Predictive Values for Preeclampsia [J]. PLoS ONE, 2014，9(12): 1-14.
[7]	Erez O, Novack L, Beer-Weisel R, et al. DIC score in pregnant women--a population based modification of the International Society on Thrombosis and Hemostasis score [J]. PLoS One, 2014，9(4): 1-10.
[8]	赵茵. 产科弥散性血管内凝血 [J]. 临床血液学杂志，2018，31(1): 10-13.

Please choose a citation manager

Content to export